At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Prevision Revision hip endoprosthesis stem implantation (device)
- How long the study runs
- Study runs about 95 months (dates as stated)
- About the drug or intervention
- Prevision Revision hip endoprosthesis stem implantation — device: The Prevision hip endoprosthetic stem is a femoral part of a hip joint endoprosthesis.
- Patient visit burden
- Not specified by the sponsor
In plain English
This study follows people who have had hip revision surgery (a second operation to replace or repair a hip implant) using a device called the Prevision hip stem. The researchers want to check how well the implant works by comparing different versions of it. It is funded by Aesculap AG, the company that makes the implant.
Who can take part
- Adults having hip revision surgery with a Prevision hip stem
- People who give written agreement (consent) to take part
- People who are able to attend follow-up check-up appointments
Who may not be able to
- People under 18 at the time of surgery
- People who were pregnant when the implant was put in
- People held in a custodial setting (for example, prison)
- People in a relationship of dependence on the sponsor, the clinic or the researcher
What taking part involves
- • Not stated — ask the trial team
Time commitment: Not stated — ask the trial team (attendance at follow-up examinations is required, but the number of visits and duration are not stated).
Plain-English summary (AI-generated) from registry data. Not eligibility advice — only the trial team can confirm whether you can take part. Use the eligibility checker to see how your health profile matches this trial.
- Type of study
- Observing health over time
- Ages
- 18 Years and over
- Who
- All
- Number of participants
- 120
- Started
- 2026-04-07
- Last checked
- 2026-04
Plain English Summary
What is this study?
- • Testing a new treatment for revision total hip arthroplasty
- • Clinical study - 120 participants
- • The study design is confirmative for non-inferiority of the functional outcome of the implants and is intended to examine the safety and performance of the Prevision hip stem
Who can take part?
- • Ages 18 Years and over
- • Diagnosed with revision total hip arthroplasty
Where?
- • Huntingdon - Hinchingbrooke Hospital
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
The study design is confirmative for non-inferiority of the functional outcome of the implants and is intended to examine the safety and performance of the Prevision hip stem. The study is an observational post-market clinical follow-up study, and the study sites chose the stem variant depending on their own routine and indication.
More detail
Generally, the advantage of the Prevision implant family is that all implant variants can be implanted with basically the same instrumentation, which makes it easier to switch to another variant. All implant variants will be available at the study sites and switching between the variants in the study will be encouraged. The aim of the study is to prove the non-inferiority of the OHS functional outcome after two years to the predecessor implant generation, and comparable revision hip stems. In addition, the patient groups treated with the different variants, and outcome of these subgroups will be descriptively compared.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 18 Years and over
- Who can join: All genders
What the study is looking for
- ✓Revision hip arthroplasty patients treated with a Prevision hip stem
- ✓Written patient agreement to take part
- ✓Patients are able to attend at follow-up examinations
Who cannot take part
- ✗Patients \< 18 years at surgery
- ✗Pregnancy at implantation
- ✗Patients held in a custodial setting
- ✗Patients in a relationship of dependence on the sponsor, the clinic or the investigator
See the full criteria
Where Is This Study? (1 UK site)
Hinchingbrooke Hospital
Huntingdon PE29 6NT, United Kingdom
How to Get in Touch
Kerstin Bergmann
Sponsor contactCONTACT
Lutz Dreyer, Dr.
Sponsor contactCONTACT